Samabriva: Funding, Investors & Team (Oct 2026)
Samabriva is a biotech company that has created a groundbreaking platform called "RHIZOBRIVA™" using plant material to produce biomolecules suitable for various industries, including pharmaceuticals, cosmetics, agrochemicals, and food. Recently, Samabriva has also established a separate division called "NANOBRIVA™" which focuses on developing orphan drugs for the treatment of lysosomal storage disorders (LSDs). This division specializes in creating novel lysosomal enzymes with improved bioavailability using an innovative technology that can be used in different production systems such as mammalian cell cultures and bacteria.
Samabriva has raised $4.3M across 1 funding round on record, the most recent a Series A of $4.3M announced in Dec 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Samabriva Company Profile and Key Stats
Latest funding round on record: Dec 2023.
Samabriva Funding Rounds
Samabriva Founders and Leadership Team
No contact details are on record for this team yet.
Samabriva Funding Compared to Other Biotechnology Startups
Samabriva's latest round of $4.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Samabriva in Biotechnology and Amiens
Companies Similar to Samabriva
WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs…
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
Samabriva Funding FAQs
What does Samabriva do?
Samabriva is a biotech company that has created a groundbreaking platform called "RHIZOBRIVA™" using plant material to produce biomolecules suitable for various industries, including pharmaceuticals, cosmetics, agrochemicals, and food. Recently, Samabriva has also established a separate division called "NANOBRIVA™" which focuses on developing orphan drugs for the treatment of lysosomal storage disorders (LSDs). This division specializes in creating novel lysosomal enzymes with improved bioavailability using an innovative technology that can be used in different production systems such as mammalian cell cultures and bacteria.
How much funding has Samabriva raised?
Samabriva has raised $4.3M across 1 round on record. The most recent is a Series A of $4.3M announced in Dec 2023.
When did Samabriva last raise funding?
Samabriva's most recent funding round on record is a Series A of $4.3M, announced in Dec 2023.
Who is the CEO of Samabriva?
Marina Guillet is listed as CEO at Samabriva.
Where is Samabriva headquartered?
Samabriva is based in Amiens, Picardie, France.
How many employees does Samabriva have?
Samabriva is in the 1-10 employee band.
How does Samabriva's funding compare to other Biotechnology startups?
Samabriva's latest round of $4.3M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Samabriva Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Samabriva is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.